long-acting injectable antipsychotics in first-episode schizophrenia
Clicks: 213
ID: 169955
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.0
/100
213 views
24 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #8 of 14 articles by views in blood and lymphatic cancer: targets and therapy
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract is not available for this article.
Login to Search Abstract
| Reference Key |
parellada2012schizophrenialong-acting
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Eduard Parellada;Dawn I. Velligan;Robin Emsley;Werner Kissling |
| Journal | blood and lymphatic cancer: targets and therapy |
| Year | 2012 |
| DOI |
10.1155/2012/318535
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.